Tag Cancer
Epigenetics researcher named Pew scholar in biomedical sciences
Peter Lewis is one of 22 biomedical scientists to win the award, meant for researchers with outstanding promise in science relevant to human health.
UW technology key to growth as firm stays in Madison long after sale
The explosion in next-generation sequencing has opened windows throughout medicine and biology.
Gene regulatory mutation linked to rare childhood cancer
This basic knowledge of a specific cancer is essential to start drug testing, says researcher Peter Lewis.
Lab keeps cancer treatment radiation machines honest
As radiation sources used to attack cancer grow in number and complexity, a UW–Madison center offers the last word on accurate radiation doses.
Antibody targets key cancer marker; opens door to better diagnosis, therapy
University of Wisconsin–Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine. In mouse models of human brain cancer, their tag is easily seen in a PET scanner, which is commonly used to detect cancer.
Drug protects fertility and may prolong life in chemo-treated mice
A University of Wisconsin–Madison physician and her research team have shown that a heart medication can prevent ovarian damage and improve survival in adolescent mice after chemotherapy. The treatment also increased the number of their healthy offspring.
Mackie honored as his latest startup shifts toward high gear
Thomas “Rock” Mackie, a scientist, entrepreneur and educator, has been honored with the 2015 Excellence in Entrepreneurial Education award for career-long assistance to students and faculty interested in starting businesses.
Compound doubles up on cancer detection
Tagging a pair of markers found almost exclusively on a common brain cancer yields a cancer signal that is both more obvious and more specific to cancer, according to a study published last week in the Proceedings of the National Academy of Sciences (PNAS).
Innovative cancer treatment machine: Still made in Wisconsin
Innovator-entrepreneur Thomas “Rock” Mackie’s TomoTherapy, launched in 1997, remains one of the universities’ most successful spinoff companies.
Cancer discovery links experimental vaccine and biological treatment
A new study at the University of Wisconsin–Madison has linked two seemingly unrelated cancer treatments that are both now being tested in clinical trials.
Study redefines role of estrogen in cervical cancer
Scientists have prior evidence that the hormone estrogen is a major driver in the growth of cervical cancer, but a new study examining genetic profiles of 128 clinical cases reached a surprising conclusion: Estrogen receptors all but vanish in cervical cancer tumors.
Navigating multiple myeloma with ‘Google Maps’ for the cancer genome
In some ways, studying the genetics of cancer has been like examining the individual tiles on a mosaic, says David C. Schwartz, a professor of genetics and chemistry at the University of Wisconsin–Madison. To make his point, he brings his face close to the table where he sits - his mosaic for the purpose of illustration - and describes the details of each imaginary tile.
Ready, aim, fire! Cancer-targeting mechanism underlies promising UW–Madison spinoff
For all their lethality, cancer cells don't look much different from healthy cells, a simple fact that causes endless pain and suffering. Finding cancer cells that have spread and threaten to grow into metastatic tumors is often a life-and-death matter.
UW-Madison cancer research showcased in Wisconsin Public Television series
Next week, cancer research by University of Wisconsin–Madison scientists will be featured in a series of programs airing on Wisconsin Public Television (WPT).
Study reveals possible biological trigger for canine bone cancer
Researchers at the University of Wisconsin–Madison School of Veterinary Medicine (SVM) have identified the biological mechanism that may give some cancer cells the ability to form tumors in dogs. The recent study uncovered an association between the increased expression of a particular gene in tumor cells and more aggressive behavior in a form of canine bone cancer. It may also have implications for human cancers by detailing a new pathway for tumor formation.
UW to test ‘breakthrough’ pediatric leukemia treatment
A promising method of immunotherapy to treat children with relapsed acute lymphocytic leukemia (ALL) is opening at the University of Wisconsin Carbone Cancer Center and American Family Children's Hospital. The trial is open to relapsed/refractory pediatric ALL patients who have limited treatment options.
UW-Madison scientists find how many cancers may evade treatment
Xiaojun Tan, a graduate student in Richard A. Anderson’s lab at the University of Wisconsin–Madison, made an unexpected observation while studying the locations inside cells where the epidermal growth factor receptor, EGFR, can be found. His subsequent investigation revealed how cancer was evading treatment drugs: by sneaking through the cellular back door.